Efficacy and Safety of Colistin Sulfate in Treating Carbapenem-Resistant Gram-Negative Bacterial Infections in Liver Transplant Recipients
Transplantation Proceedings · 2026-07 · 58 (6) · 1097-1103
DOI: 10.1016/j.transproceed.2026.06.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2026-07. Verfasst von Yun Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Shulan (Hangzhou) Hospital, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China. Hauptthemen laut MEDLINE: Colistin, Liver Transplantation, Gram-Negative Bacterial Infections, Anti-Bacterial Agents. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Hangzhou Municipal Health Commission.
Abstract (Originalsprache)
OBJECTIVE: Carbapenem-resistant Gram-negative bacteria (CR-GNB), including carbapenem-resistant Enterobacterales (CRE), carbapenem-resistant Pseudomonas aeruginosa (CRPA), and carbapenem-resistant Acinetobacter baumannii (CRAB), are critical postoperative complications in liver transplant recipients. This study aimed to evaluate the clinical efficacy and safety of intravenous colistin sulfate (CS) in treating CR-GNB infections in liver transplant patients and identify independent predictive factors influencing therapeutic outcomes. METHODS: A retrospective cohort of 20 liver transplant recipients with CR-GNB infections admitted to the intensive care unit (ICU) was included. Patients received intravenous colistin sulfate and were stratified into an effective treatment group (n = 10) and an ineffective group (n = 10) based on clinical response. Baseline clinical data and laboratory parameters were collected. Chi-square tests and t-tests compared differences between groups. Logistic regression and receiver operating characteristic (ROC) curve analyses were performed to identify independent predictors of CS efficacy. RESULTS: Significant differences in serum procalcitonin (PCT) and tumor necrosis factor-alpha (TNF-α) levels were observed between the effective and ineffective groups (P < .05). Multivariate analysis identified TNF-α (OR = 1.009, 95% CI: 0.955-1.066; P = .049) and PCT (OR = 0.590, 95% CI: 0.350-0.997; P = .049) as independent predictors of treatment efficacy. ROC curve analysis demonstrated that TNF-α alone predicted efficacy with an area under the curve (AUC) of 0.900 (specificity=100%, sensitivity=70%), while PCT showed an AUC of 0.885 (specificity = 100%, sensitivity = 80%). Combined TNF-α and PCT improved predictive accuracy (AUC = 0.970, specificity = 100%, sensitivity = 90%). CONCLUSION: TNF-α and PCT serve as reliable biomarkers for optimizing colistin sulfate therapy in liver transplant recipients with CR-GNB infections. Dynamic monitoring of these inflammatory markers during treatment may enhance therapeutic outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Shulan (Hangzhou) Hospital, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China.
- School of Medicine, Zhejiang Chinese Medical University, Shuren College, Hangzhou, China.
- Department of Hepatobiliary Surgery Shulan (Hangzhou) Hospital, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China.
- The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- Department of Pharmacy Shulan (Hangzhou) Hospital, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China. Electronic address: yanli.wu@shulan.com.
- Department of infectious Shulan (Hangzhou) Hospital, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China. Electronic address: linglingtangshulan@163.com.
Förderung
- Hangzhou Municipal Health Commission
Zitieren
APA
Chen, Y., Fang, Z., Liu, X., Pan, Y., Zheng, W., Hong, H., Xu, T., Wu, Y., & Tang, L. (2026). Efficacy and Safety of Colistin Sulfate in Treating Carbapenem-Resistant Gram-Negative Bacterial Infections in Liver Transplant Recipients. Transplantation Proceedings, 58(6), 1097-1103. https://doi.org/10.1016/j.transproceed.2026.06.013
Vancouver
Chen Y, Fang Z, Liu X, Pan Y, Zheng W, Hong H, et al. Efficacy and Safety of Colistin Sulfate in Treating Carbapenem-Resistant Gram-Negative Bacterial Infections in Liver Transplant Recipients. Transplantation Proceedings. 2026;58(6):1097-1103. doi:10.1016/j.transproceed.2026.06.013
BibTeX
@article{Chen2026,
author = {Chen, Yun and Fang, Zhongbiao and Liu, Xiangyan and Pan, Yinglu and Zheng, Wen and Hong, Huijuan and Xu, Tingwei and Wu, Yanli and Tang, Lingling},
title = {Efficacy and Safety of Colistin Sulfate in Treating Carbapenem-Resistant Gram-Negative Bacterial Infections in Liver Transplant Recipients},
journal = {Transplantation Proceedings},
year = {2026},
volume = {58},
number = {6},
pages = {1097--1103},
doi = {10.1016/j.transproceed.2026.06.013}
}
EUVIMED